Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This study compares paclitaxel/carboplatin (PC) to PC chemotherapy followed by gefitinib for
2 weeks in patients with Non-small Cell Lung Cancer (NSCLC) without epidermal growth factor
receptor (EGFR) mutations.
Expanded acronym : [P]aclitaxel/Ca[r]boplatin (PC) followed by Gef[i]tinib in A[d]vanc[e]d
Non-small Cell Lung Cancer (NSCLC): Randomized phase II study.